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a b s t r a c t
Depression and cardiovascular diseases (CVD) are both common illnesses. Several stud-
ies demonstrated that depressed individuals have higher mortality compared to age- and
gender-matchedpopulation,with anexcess of cardiovascular deaths. There is a bidirectional
association between depression and CVD. Several factors can interact and inﬂuence this
relationship: poverty and social inequality, reduced accessibility to health care, biological
alterations (as reduced heart rate variability, endothelial dysfunction, increased inﬂam-
mation and platelet function, and hyperactivity of hypothalamic-pituitary-adrenal axis),
side effects of psychiatric medication, lower adherence to medical treatments, and higher
frequency of cardiovascular risk factors (higher tobacco use, physical inactivity, obesity, dia-
betes mellitus). This article aims to update the current evidence of the possible mechanisms
involved in the association between depression and CVD.
© 2013 Elsevier Editora Ltda.
Risco cardiovascular em indivíduos com depressão
Palavras chave:
Doenc¸a cardiovascular
Fatores de risco
Transtornos depressivos
Depressão
r e s u m o
Adepressão e as doenc¸as cardiovasculares (DCV) são patologias frequentes. Estudos demon-
stram que indivíduos deprimidos têm maior mortalidade quando comparados a indivíduos
do mesmo sexo e faixa etária, com um excesso de mortes por doenc¸as cardiovasculares.
Há uma associac¸ão bidirecional entre depressão e doenc¸as cardiovasculares. Vários fatores
podem interagir e inﬂuenciar esta relac¸ão: a pobreza e a desigualdade social, diﬁculdade
de acesso a cuidados de saúde, alterac¸ões biológicas (menor variabilidade da frequência
cardíaca, disfunc¸ão endotelial, atividade inﬂamatória e func¸ão plaquetária aumentadas,
hiperatividade do eixo hipotálamo-hipóﬁse-adrenal), efeitos colaterais de medicac¸ões
psiquiátricas, menor adesão aos tratamentos e maior frequência de fatores de risco
 Study conducted at Centro de Saúde Escola Barra Funda “Dr. Alexandre Vranjac”, Irmandade da Santa Casa de Misericórdia de São
Paulo, São Paulo, SP, Brazil.
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cardiovasculares (pior estilo de vida, maior frequência de tabagismo e inatividade física e
maior prevalência de obesidade e diabetes mellitus). O objetivo deste artigo é revisar as
evidências sobre a associac¸ão entre depressão e doenc¸as cardiovasculares.
© 2013 Elsevier Editora Ltda.
Introduction
Depression is the leading cause of disability (measured by
years lived with disability), and the fourth leading cause
of disease burden worldwide.1 It is a common disorder;the
World Mental Health Survey found a lifetime prevalence of
depression of 14.6% in developed countries and of 11.1% in
developing countries. The same study found a lifetime preva-
lence of depression in the metropolitan region of São Paulo of
18.4%.2
Several studies point to a higher mortality in individuals
with psychiatric disorders, including depressive subjects.3–8
This is partly explained by a high suicide rate, but these
individuals also present high all-cause and cardiovascular
mortality.5,9,10 Cardiovascular disease (CVD) is the leading
cause of death worldwide, and also in Brazil.1,11 As described
above, the impact of CVD among people with mental disor-
ders (including depression) is higher than observed in general
population.
There are severalmechanisms that can inﬂuence this asso-
ciation: psychotropic medication side effects, poor lifestyle,
reduced access to health care, increased frequency of smok-
ing, and association with cardiovascular risk factors. The aim
of this article is to review the evidence on the different fac-
tors that can inﬂuence the increased cardiovascular risk in
individuals previously diagnosed with depression.
Depression, mortality, and cardiovascular
events
Despite the known impact of depression on quality of life,
the association between increased mortality and depression
may be usually unrecognized by physicians. The ﬁrst study
that showed higher mortality in psychiatric patients was
published in 1841, conducted by the British epidemiologist
William Farr.12,13 According to that study, inpatients with
mental illness in London had three to 14 times higher all-
cause mortality compared to the general population. Recent
studies support these results, considering either individuals
with severe psychiatric disorders or only those with depres-
sion. Most studies observed that CVD was the main cause of
death.3,8,14–23
An English cohort of mental health service users with a
three-year follow-up was conducted between 2007 and 2009,
and included 11,697 individuals with depressive disorders. It
was found a standardized mortality ratio of 1.53 (95% CI: 1.36
to 1.72) in men and 1.18 (95% CI: 1.06 to 1.31) in women.6 The
National Health Interview Survey evaluated 57,897 white indi-
viduals in the United States aged 25 years or older in 1989, and
their vital status in the National Death Index after two years.
A total of 615 individuals were depressed in that survey. The
relative risk for death by all causes in men was 2.4 (95% CI:
1.4 to 4.2). However, no difference was found for depressive
women.4
A Danish register-based cohort with 5,558,959 individuals
veriﬁed cause-speciﬁc mortality and its association with hos-
pital admission for psychiatric conditions. Patients admitted
with unipolar depressive disorder had higher mortality rates
in all age groups. Therewere highermortality rate ratios (MRR)
for cardiovascular causes in both men (MRR 1.59; 95% CI:
1.53 to 1.65) and women (MRR 1.47; 95% CI: 1.43 to 1.52).20
Most studies support these ﬁndings, with higher mortality
and higher proportion of cardiovascular deaths in depressed
individuals (Table 1).3,8,14–21,24
There is also consistent evidence on the association
between depression and non-fatal cardiovascular events
(myocardial infarction and coronary artery disease). This asso-
ciation is bidirectional: individuals with depression have a
higher incidence of CVD and individuals with CVD (mainly
acute events) have a higher incidence of depression.25–27 Two
systematic reviews have studied the impact of depression
on the incidence of cardiovascular events. Hemingway et al.
observed an increased incidence of CVD in individuals with
depression. The relative risk (RR) in the included studies
ranged from 1.23 to 5.4.26 Wulsin et al. found a combined RR
for cardiovascular events in patients with depression of 1.64
(95% CI: 1.41 to 1.90).25
Mechanisms of association
The association between depressive disorders and the inci-
dence of cardiovascular events is explained by several factors,
detailed below. Table 2 shows the known possible mecha-
nisms of association between depressive disorders and the
incidence of CVDs.
Vulnerability and accessibility
According to the World Health Organization (WHO), peo-
ple with mental health conditions, including depression,
should be considered a vulnerable group, ensuring their inclu-
sion in development programs and strategies of promotion
and protection of their rights. Vulnerable individuals share
common challenges in the exercise of their civil and polit-
ical rights; have higher rates of stigma, discrimination, and
decreased employment and educational opportunities; suffer
violence and abuse; and have reduced access to health and
social services.28 The International Guidelines for Biomedical
Research Ethics deﬁnes vulnerability as the inability to protect
one’s own interests, including any group or individual charac-
teristic that could reduce the ability of self-determination.29
There is substantial evidence to support that people with
mental disorders have experienced more physical or sexual
violence than the general population. They are more often
stigmatized, resulting in barriers in ﬁnding employment, and
Este é um artigo Open Access sob a licença de CC BY-NC-ND
300 rev assoc med bras . 2013;59(3):298–304
Table 1 – Studies evaluating all-cause and cardiovascular mortality in individuals previously diagnosed with depression.
Author and year of publication Study design and population Sample size Results
Zheng D, 19974 Cohort in the United States 57,897 white individuals
615 depressed individuals
Death from all causes RR 2.4
(95% CI: 1.4 to 4.2) in male
subjects
No higher mortality in women
(RR 1.0; 95% CI: 0.4 to 2.6)
Whooley M, 19987 Cohort (Study of Osteoporotic
Fractures)
7,518 elderly white women
473 depressed women
RR 2.14 (95% CI: 1.75 to 2.61) for
all-cause mortality and RR 1.8
(95% CI: 1.2 to 2.5) from
cardiovascular diseases
Laursen TM, 200720 Register-based cohort
in Denmark
5,558,959 individuals
Subjects with hospital
admissions
72,165 individuals admitted
with unipolar depression
Mortality rate ratio for
cardiovascular causes 1.59 (95%
CI: 1.53 to 1.65) in men and 1.47
(95% CI: 1.43 to 1.52) in women
Lin EHB, 200957 Cohort in the United States 4,184 diabetic subjects
493 depressed individuals
Hazard ratio 1.52 (95% CI: 1.19
to 1.95) for all-cause mortality,
but no higher mortality for
cardiovascular diseases (HR
1.25; 95% CI: 0.83 to 1.86)
Chang CK, 20106 Register-based cohort
in Southeast London
11,697 subjects with depressive
disorders
Standardized mortality ratio
1.53 (95% CI: 1.36 to 1.72) in
men and 1.18 (95%CI: 1.06 to
1.31) in women
Almeida OP, 20105 Cohort in Perth, Australia 5,276 non-institutionalized
elderly men and 297 depressed
men
Standardized mortality ratio
1.98 (95% CI: 1.61 to 2.43) for
all-cause mortality and 2.69
(95% CI: 2.01 to 3.59) for
cardiovascular causes
Laan W, 201122 Register-based cohort
in Netherlands
103,824 individuals without
psychiatric diagnosis and
14,778 depressed individuals
Hazard ratio 1.83 (95% CI: 1.72
to 1.95) for all-cause mortality
and 1.63 (95% CI: 1.45 to 1.83)
from circulatory diseases
Patten SB, 201124 Cohort in Canada 17,276 individuals No higher mortality
Hazard ratio 1.1 (95% CI: 0.7
to 1.7)
Pan A, 201123 Cohort in the United States
(Nurses’ Health Study)
78,282 women aged 54 to
79 years
11,120 depressed women
RR 1.76 (95% CI: 1.64 to 1.89) for
all-cause mortality and RR 1.81
(95% CI: 1.54 to 2.13) for
cardiovascular diseases
Gale C, 201219 Register-based cohort in
Sweden
1,095,338 men and 9,237
depressed individuals
Hazard ratio for all-cause
mortality 1.51 (95% CI: 1.26
to 1.81)
are restricted in their ability to access essential health care
and social care.28
People with mental health conditions are largely over-
looked by government policies and programs around the
world, also resulting in reduced access and low quantity and
quality of health and social services. WHO estimates that 75%
to 85% of individuals with mental disorders living in low and
middle income countries do not have access to mental health
treatment.28
There is considerable data showing that part of CVDburden
in individuals with psychiatric disorders could be explained
by lower accessibility to effective health services and poorer
quality of health care.9,10,14 Accessibility is a complex concept
deﬁned as “the features of health services and resources that
favor or limit the utilization by potential users”.30 Accessibility
also reﬂects patients’ characteristics (such as empowerment,
social support, educational level) and health system features
(such as barriers to health care, and quality and quantity of
health services).
Kisely et al. evaluated data on health insurance users in
Nova Scotia (Canada) between 1995 and 2001, and found that
cardiovascular mortality in psychiatric patients was greater
than in the general population. However, they found that the
odds ratio (OR) of undergoing cardiac catheterization was sig-
niﬁcantly smaller (OR 0.92; 95% CI: 0.86 to 0.98) for individuals
with psychiatric conditions. Additionally, rates of percuta-
neous angioplasty and open revascularization also had a
non-signiﬁcant trend to be smaller (OR 0.97, 95% CI: 0.86 to
1.09; and OR 0.92, 95% CI: 0.83 to 1.02, respectively) in that
group.10
Druss et al. evaluated 88,241 elderly patients with previous
myocardial infarction included in the Cooperative Cardiovas-
cular Project, and observed that patients with psychiatric
diseases other than dementia or delirium were less likely to
undergo myocardial reperfusion therapy (RR 0.87; 95% CI: 0.79
to 0.95), even in the absence of any contraindication to the
procedure.9 The authors found higher rates of acute myocar-
dial infarction mortality (RR 1.11; 95% CI: 1.02 to 1.20) in
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Table 2 – Possible mechanisms of association between
depressive disorders and the incidence of cardiovascular
diseases.
a) Social inequality and poverty28
b) Side effects of psychiatric medication45
c) Lower adherence to medical treatments33
d) Biological alterations27,34–37
Increased platelet activation
Increased endothelial dysfunction
Elevated C-reactive protein
Elevated interleukin-6
Elevated tumor necrosis factor
Increased resting heart rate
Reduced heart rate variability
Greater QT interval variability
e) Genetic mechanisms40
f) Reduced accessibility to health care9,10,14,28
g) Higher frequency of cardiovascular risk factors41–57
Tobacco smoking
Sedentary lifestyle
Diabetes mellitus
Obesity and metabolic syndrome (in depressed women)
patients with mood disorders. After adjustment for variables
associated with the quality of medical care in this scenario
(frequency of prescribed reperfusion therapy, aspirin, beta-
blockers, and angiotensin-converting enzyme inhibitors at
hospital discharge whenever indicated), this difference dis-
appears (RR 1.05; 95% CI: 0.87 to 1.23). This suggests that the
association of myocardial infarction mortality in patients with
mood disorders is mediated by health care access, an indi-
rect evidence that people with mental health conditions may
also suffer prejudice and discrimination by mental health care
workers.28
In order to enhance the universality of access andquality of
care, theWHO suggests thatmental health care should be pro-
vided in primary care settings, integrated with general health
services.28 It is necessary to coordinate between medical and
mental facilities, removing boundaries in order to improve
communication and facilitate the development of common
goals between medical and mental care providers.31
Adherence
Adherence to medical treatment is another mechanism of
association between the presence of depressive disorders and
onset of CVD. Four main interacting elements can inﬂuence
patients’ adherence: health care team and health care sys-
tem (costs of treatment, availability of treatment in health
system, easily accessibility of medical services and proce-
dures); condition-related factors (features of the disease that
can contribute to the adherence, such as memory distur-
bances, as seen in depression); therapy characteristics (side
effects, medications that have to be used several times a
day); and patient-related issues (ideas and feelings about the
disease and treatment, expectations, resiliency, conﬁdence in
the health professional).32
Depressed patients have lower adherence to treatment,
resulting in greater impact of chronic medical comorbidities.
DiMatteo et al. found an OR of 3.03 (95% CI: 1.96 to 4.89) for
non-adherence to treatment recommendations in peoplewith
depression.33 Both condition- and patient-related factors can
interact and reduce adherence in depressed patients. Some
of the features of depressive disorders can reduce adherence,
such as diminished memory, anhedonia, negative thoughts,
and depressed mood.
Biological alterations
Several biological changes inﬂuence the incidence of CVD
in depressed individuals. Hypothalamus-hypophysis-adrenal
axis hyperactivity has been described.27,34–37 Increased res-
ting heart rate, reduced heart rate variability, and greater
QT interval variability on the electrocardiogram may lead
to ventricular arrhythmias and sudden death.34 There are
reports of increased platelet activation associated with
depression, increased inﬂammatory activity, and endothelial
dysfunction.34,36,37 There are studies showing higher levels of
inﬂammatorymarkers such as C-reactive protein, interleukin-
6, and tumor necrosis factor, which may all have a role in
triggering an acute coronary event.37–39
Genetic-based theories for this association have also been
raised. Vaccarino et al. evaluated 289 monozygotic and dizy-
gotic twins where only one of the siblings had the diagnosis of
depression. No differences were observed for signs of myocar-
dial ischemia between twins with and without a diagnosis of
depression. However, a difference in coronary computerized
tomography was observed among dizygotic twins, with the
worst function in those individuals with a history of depres-
sion. In monozygotic twins, this difference was not found,
suggesting a role for genetic mechanisms.40
Classic risk factors for CVD
Several studies showed a higher frequency of some car-
diovascular risk factors among individuals with depressive
disorders, which can also explain the higher incidence of
cardiovascular events. There is consistent evidence that asso-
ciates poorer lifestyle and depression. Strine et al., evaluating
217,379 participants in a phone-based American survey, found
that individuals with a current episode of depression were
more frequently smokers (OR 2.2; 95% CI: 2.0 to 2.3) and seden-
tary (OR 2.1; 95% CI: 1.9 to 2.3). Similar results were found in
individuals with prior diagnosis of depression (OR 1.9; 95%
CI: 1.8 to 2.1 for smoking and OR 1.3; 95% CI: 1.2 to 1.4 for
sedentarism).41
The association between obesity and depression is con-
sistent for the female gender.42,43 Simon et al. evaluated
9,125 individuals in a population prevalence study (National
Comorbity Survey Replication) and observed that obesity was
associated with a lifetime diagnosis of depression (OR 1.21;
95% CI: 1.09 to 1.35). However, when the analysis was strat-
iﬁed by gender, the difference occurred only in women (OR
1.29; 95% CI: 1.11 to 1.50).42 This association may be partially
mediated by the use of antidepressants, which could cause
weight gain as side effect.44
There is an association between the presence of depres-
sion and the incidence of diabetes mellitus. In a systematic
review of nine cohort studies, Knol et al. found a combined RR
of 1.37 (95% CI: 1.14 to 1.63) for the development of diabetes
mellitus in depressive subjects.45 Similar results were found
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by Mezuk et al. (combined RR 1.60; 95% CI: 1.37 to 1.88).46 Part
of this effect may be caused by the use of antidepressants.
Andersohn et al., in a nested case-control study, found that
individuals who used antidepressants in moderate to high
doses for periods greater than 24 months had higher risk of
incident diabetes (OR 1.84; 95% CI: 1.35 to 2.52). It is notice-
able that this is not fully explained by the use of tricyclic
antidepressants and their associated weight gain. Higher dia-
betes incidence was also found among depressive individuals
treated with selective serotonin reuptake inhibitors.47 Con-
versely, diabetes may also precede the onset of depression.
Mezuk et al. also found a combined RR of 1.15 (95% CI: 1.02 to
1.30) for depression in individuals with diabetes, reinforcing
the positive link between these two conditions.46
Metabolic syndrome is also more frequent in depressed
women. Raikkonen et al. followed 432 premenopausal women
in the Healthy Women Study cohort for 15 years. Depressive
symptomswere associatedwith higher incidence ofmetabolic
syndrome,with a RR of 1.29 (95%CI: 1.04 to 1.60).48 Kinder et al.
published a study of cross-sectional data from the National
Health andNutrition Examination Survey III (NHANES III) with
6,189 individuals aged between 17 and 39 years, and observed
a positive association between the presence of metabolic syn-
drome and lifetime history of major depression in women,
with an OR of 1.96 (95% CI: 1.03 to 3.73). No association was
found in men.49
Regarding the association between depression and hyper-
tension or dyslipidemia, data are contradictory and suggest
that there is no signiﬁcant link.50–56
Final considerations
The increased all-cause and cardiovascular mortality in indi-
viduals with depression demonstrated in most studies could
be affected by several factors. Studies evaluating these fac-
tors, however, have some limitations. There is heterogeneity
in the criteria used to deﬁne depression, as several different
questionnaires were used. Additionally, some instruments are
validated only for depressive symptoms, but not for deﬁnitive
diagnosis. Few studies used psychiatric evaluation or semi-
structured interviews, which have better reliability. Another
limitation is that some cohorts did not assess confounding
variables related to clinical comorbidity, adherence, andacces-
sibility.
Increased cardiovascular risk among individuals with
depression is multifactorial and requires several strategies
towards cardiovascular risk reduction.Development of antide-
pressant treatments targeted to less weight gain and less
insulin resistance may also lower cardiovascular risks in
individuals with depression. Education of health care profes-
sionals, including those working in primary care, is required
to improve detection and treatment of depression, and also
to enhance surveillance and management of concurrent car-
diovascular risk factors in depressed individuals. Few data
are currently available on strategies for tobacco cessation and
for increasing physical activity in people with depression.31
Development in this area is necessary in order to offset the
inﬂuence of these factors on cardiovascular risk in this group.
Health system managers, as suggested by the WHO, should
also create health policies to reduce vulnerability in this
population.28
Conclusion
Cardiovascular risk is higher in individuals with depres-
sion. This association is at least partly explained by higher
vulnerability, reduced access to health care services, lower
adherence, biological alterations, use of psychiatric medi-
cation, and higher frequency of classic cardiovascular risk
factors.
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